Chemistry, toxicology & urinalysis
Management
Assay interferences
Author: Felix Leung, Ph.D.
Deputy Editor-in-Chief: Patricia Tsang, M.D., M.B.A.
Last author update: 11 May 2021
Last staff update: 11 May 2021
Copyright: 2021, PathologyOutlines.com, Inc.
PubMed Search: Assay interferences[TIAB]
Table of Contents
Definition / general | Essential features | Terminology | Types of interferences | Mechanisms of interference | Serum indices | Other common interferents | Strategies to handle interferents | Board review style question #1 | Board review style answer #1Cite this page: Leung F. Assay interferences. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/chemistryassayinterferences.html. Accessed April 18th, 2024.
Definition / general
- Interference is defined as a cause of clinically significant difference in the assay result, due to another component or property of the sample
- Most interferences are missed by quality control processes and can lead to undetected discrepant test results, which can lead to patient harm
Essential features
- HIL (hemolysis, icterus, lipemia) interference can be detected on most automated analyzers
- Other types of interference are often missed and require awareness by both laboratorians and clinicians
- Use Clinical and Laboratory Standards Institute (CLSI) EP07 as a resource for interference testing (CLSI: EP07 - Interference Testing in Clinical Chemistry [Accessed 16 April 2021])
Terminology
- Analyte: component represented in the name of a measurable quantity
- Matrix: all components of a material system, except the analyte
- Measurand: particular quantity subject to measurement
Types of interferences
- Interferents can originate from both exogenous and endogenous sources (Clin Chem Lab Med 2020;58:350)
- Endogenous:
- Metabolites that arise from pathological conditions (free hemoglobin, bilirubin, lipidemia)
- Macrocomplexes (macroprolactin, macroenzymes)
- Antianalyte antibodies (antithyroglobulin)
- Paraproteins
- Specimen matrix itself
- Exogenous:
- Compounds given to patient for treatment (e.g. drugs, anticoagulants, intravenous saline or dextrose solutions)
- Ingested substances (biotin, a type of vitamin B)
- Environmental contaminants (powder from gloves, atmospheric air)
- Sample additives from phlebotomy processes (anticoagulants, preservatives)
- Identifying the presence of most interferents depends on clinicians recognizing discordant test results and communicating with laboratorians
Mechanisms of interference
- Broad categories of interference include:
- Chemical interference: interferent disrupts assay reaction
- Spectral interference: interferent has similar spectral properties to the measurand
- Physical interference: interferent alters physical properties of the sample or measurand
- Enzymatic interference: interferent alters activity of enzyme(s) used in the assay reaction
- Nonselectivity: interferent mimics measurand in the assay reaction
- Additive interference: interferent or additional measurand introduced into sample
- The same interferent can interfere differently, depending on the assay
- In vitro hemolysis can cause chemical interference (hemoglobin inhibits certain reactions), spectral interference (hemoglobin has characteristic red color) and additive interference (red blood cells have high intracellular concentrations of certain analytes, e.g. potassium, lactate dehydrogenase, magnesium, phosphorus and AST)
- Critical to assess interferent in context of assay in question
- Reference: Rifai: Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 6th Edition, 2017
Serum indices
- Most high volume automated analyzers can measure serum HIL (hemolysis, icterus, lipemia) indices on patient samples
- Assays susceptible to HIL interference can be set to flag patient results, if indices are present above established threshold
- Manufacturers will typically provide HIL interference data in assay information but may still require laboratory verification / validation (refer to CLSI guidelines) (CLSI: C56 - Hemolysis, Icterus, and Lipemia/Turbidity Indices as Indicators of Interference in Clinical Laboratory Analysis [Accessed 16 April 2021])
- Serum indices are measured photometrically based on characteristic absorbance (Ann Clin Biochem 2016;53:527):
- Hemolysis absorbs light between 340 - 440 nm and 540 - 580 nm
- Bilirubin (icterus) absorbs light between 400 - 500 nm
- Lipemia (caused by lipid particles) can absorb light between 300 - 700 nm
Common tests affected by HIL interference:
| | | |
| Hemolysis |
|
|
Icterus |
| |
| Lipemia |
| |
|
||
Other common interferents
- Biotin (vitamin B7) will interfere with immunoassays that use the streptavidin - biotin system
- Interference can be negative or positive, depending on assay format (i.e. competitive or noncompetitive)
- Heterophilic antibodies can interfere with any type of immunoassay
- Defined as antibodies that can react nonspecifically with different molecules
- Typically causes false positive sandwich immunoassay result but may also cause false negative results
- Often increased in patients with autoimmune or inflammatory conditions
- Human antianimal antibodies can interfere with immunoassay, if it uses antibodies produced by the animal in question
- Most frequent cause is human antimouse antibodies
- Macrocomplexes (endogenous analytes that self polymerize or complex with immunoglobulins) will cause discrepantly high results that are not indicative of patient status
- Most commonly affected tests are aspartate aminotransferase, creatine kinase, amylase and prolactin
- Reference: Rifai: Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 6th Edition, 2017
Strategies to handle interferents
- HIL interferences should be thoroughly assessed and validated prior to implementation of an assay
- Use manufacturer provided information and CLSI guidelines (C56-A and EP07) as reference (CLSI: C56 - Hemolysis, Icterus, and Lipemia/Turbidity Indices as Indicators of Interference in Clinical Laboratory Analysis [Accessed 16 April 2021], CLSI: EP07 - Interference Testing in Clinical Chemistry [Accessed 16 April 2021])
- Rare or unexpected interferents can be handled with alternative solutions (though none are guaranteed):
- Dilute the interferent out with appropriate diluent
- Remove the interferent with treatment (i.e. polyethylene glycol [PEG] precipitation for macrocomplexes)
- Estimate the degree of discrepancy caused by interferent
Board review style question #1
Which of the following statements about assay interferences is true?
- An interferent typically exhibits the same interference properties across different assays
- Interferents exhibit similar interference properties across different assays
- The recognition of assay interference by biotin and heterophilic antibodies often depends on awareness by clinicians
- Most automated analyzers are unable to detect HIL (hemolysis, icterus, lipemia) interferences
Board review style answer #1
C. The recognition of assay interference by biotin and heterophilic antibodies often depends on awareness by clinicians
Comment Here
Reference: Assay interferences
Comment Here
Reference: Assay interferences
